{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:42:19Z","timestamp":1792082539260,"version":"4.4.0"},"reference-count":623,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1124\/pr.107.00107","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T15:10:55Z","timestamp":1224083455000},"page":"358-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":197,"title":["Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection"],"prefix":"10.1016","volume":"60","author":[{"given":"Jeffrey A.","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Bymaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Y.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel Y.","family":"Deutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary E.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June R.","family":"Aprille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donard S.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahebarao P.","family":"Mahadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine S.","family":"Modica-Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Csernansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.107.00107_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00210-006-0115-9","article-title":"Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex","volume":"374","author":"Abekawa","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pr.107.00107_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0074-7742(06)78005-9","article-title":"Alterations of serotonin transmission in schizophrenia","volume":"78","author":"Abi-Dargham","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pr.107.00107_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eurpsy.2004.11.003","article-title":"Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies","volume":"20","author":"Abi-Dargham","year":"2005","journal-title":"Eur Psychiatry"},{"key":"10.1124\/pr.107.00107_bib4","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1523\/JNEUROSCI.22-09-03708.2002","article-title":"Prefrontal dopamine D1 receptors and working memory in schizophrenia","volume":"22","author":"Abi-Dargham","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1073858403252674","article-title":"Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia","volume":"9","author":"Abi-Dargham","year":"2003","journal-title":"Neuroscientist"},{"key":"10.1124\/pr.107.00107_bib6","first-page":"326","article-title":"Examination of the involvement of protein kinase A in D2 dopamine receptor antagonist-induced immediate early gene expression","volume":"77","author":"Adams","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib7","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1523\/JNEUROSCI.18-14-05545.1998","article-title":"Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine","volume":"18","author":"Adams","year":"1998","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib8","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0006-3223(01)01195-7","article-title":"Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex","volume":"50","author":"Adams","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","article-title":"The Bcl-2 protein family: arbiters of cell survival","volume":"281","author":"Adams","year":"1998","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib10","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1073\/pnas.94.22.12157","article-title":"Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice","volume":"94","author":"Adams","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib11","doi-asserted-by":"crossref","first-page":"14033","DOI":"10.1073\/pnas.241503698","article-title":"The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms?","volume":"98","author":"Akwa","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.59.8.705","article-title":"Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia","volume":"59","author":"Albert","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/pr.107.00107_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF00445551","article-title":"Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment","volume":"99","author":"Alfredsson","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.biopsych.2004.11.036","article-title":"Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum","volume":"57","author":"Alimohamad","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000119364","article-title":"Haloperidol administration in humans lowers plasma nerve growth factor level: evidence that sedation induces opposite effects to arousal","volume":"36","author":"Aloe","year":"1997","journal-title":"Neuropsychobiology"},{"key":"10.1124\/pr.107.00107_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1017\/S1461145705005900","article-title":"Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine","volume":"9","author":"Amarg\u00f3s-Bosch","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0893-133X(02)00287-7","article-title":"Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs","volume":"27","author":"Andersson","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archpsyc.1992.01820120031006","article-title":"Hypofrontality in neuroleptic-na\u00efve patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London","volume":"49","author":"Andreasen","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/BF02245864","article-title":"The mitochondrial toxin 3-nitropropionic acid induces vacuous chewing movements in rats. Implications for tardive dyskinesia?","volume":"119","author":"Andreassen","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats: implications for tardive dyskinesia","volume":"61","author":"Andreassen","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1124\/pr.107.00107_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1461145700001759","article-title":"Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions","volume":"3","author":"Angelucci","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euroneuro.2004.11.005","article-title":"Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain","volume":"15","author":"Angelucci","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M","article-title":"Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration","volume":"60","author":"Angelucci","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0006-8993(01)03026-8","article-title":"Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine","volume":"923","author":"Ardizzone","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neures.2006.10.021","article-title":"Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions","volume":"57","author":"Arif","year":"2007","journal-title":"Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0773.1982.tb01032.x","article-title":"Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade","volume":"51","author":"Arnt","year":"1982","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1124\/pr.107.00107_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0143-4160(03)00141-6","article-title":"Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity","volume":"34","author":"Arundine","year":"2003","journal-title":"Cell Calcium"},{"key":"10.1124\/pr.107.00107_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(24)37013-2","article-title":"Clozapine and haloperidol modulate N-methyl-d-aspartate- and non-N-methyl-d-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro","volume":"283","author":"Arvanov","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0006-8993(02)03176-1","article-title":"Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus","volume":"956","author":"Ashe","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000054950","article-title":"Serum leptin and cholesterol values in suicide attempters","volume":"45","author":"Atmaca","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1124\/pr.107.00107_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","article-title":"Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs","volume":"71","author":"Bai","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10290","article-title":"Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal","volume":"69","author":"Bai","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2004.02.064","article-title":"Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus","volume":"1010","author":"Bai","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ajmg.b.30291","article-title":"Association of AKT1 haplotype with the risk of schizophrenia in Iranian population","volume":"141B","author":"Bajestan","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1124\/pr.107.00107_bib37","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/0006-2952(72)90183-9","article-title":"Effects of psychotropic drugs on the erythrocyte permeability to glucose and ethylidene glucose","volume":"21","author":"Baker","year":"1972","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.107.00107_bib38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02246096","article-title":"Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine","volume":"122","author":"Bakshi","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib39","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0022-3565(25)23831-9","article-title":"Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response","volume":"271","author":"Bakshi","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-12-152829-4.50008-2","article-title":"Function and regulation of the pentose phosphate pathway in brain","volume":"29","author":"Baquer","year":"1988","journal-title":"Curr Top Cell Regul"},{"key":"10.1124\/pr.107.00107_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0893-133X(01)00254-8","article-title":"Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat","volume":"25","author":"Barbaccia","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib42","first-page":"45","article-title":"Neurotrophins: a family of proteins supporting the survival of neurons","volume":"390","author":"Barde","year":"1994","journal-title":"Prog Clin Biol Res"},{"key":"10.1124\/pr.107.00107_bib43","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.107.00107_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archpsyc.58.5.461","article-title":"Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study","volume":"58","author":"Bartzokis","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.107.00107_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/\u03b2-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"10.1124\/pr.107.00107_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(89)90077-0","article-title":"Anticonvulsant profile of the progesterone metabolite 5 \u03b1-pregnan-3 \u03b1-ol-20-one","volume":"166","author":"Belelli","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib48","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1471-4159.2002.01263.x","article-title":"Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine","volume":"83","author":"Ben-Shachar","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0074-7742(04)59011-6","article-title":"Mitochondria, synaptic plasticity, and schizophrenia","volume":"59","author":"Ben-Shachar","year":"2004","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pr.107.00107_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-3956(96)00044-1","article-title":"The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia","volume":"31","author":"Benes","year":"1997","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pr.107.00107_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1749-6632.2000.tb06733.x","article-title":"Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia","volume":"911","author":"Benes","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/pr.107.00107_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","article-title":"GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder","volume":"25","author":"Benes","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/(SICI)1098-2396(199604)22:4<338::AID-SYN5>3.0.CO;2-C","article-title":"Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain","volume":"22","author":"Benes","year":"1996","journal-title":"Synapse"},{"key":"10.1124\/pr.107.00107_bib54","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archpsyc.1991.01810350036005","article-title":"Deficits in small interneurons in prefrontal and cingulated cortices of schizophrenic and schizoaffective patients","volume":"48","author":"Benes","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib55","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0306-4522(96)00328-4","article-title":"Increased GABAA receptor binding on neurons of prefrontal cortex in schizophrenic subjects","volume":"75","author":"Benes","year":"1996","journal-title":"Neuroscience"},{"key":"10.1124\/pr.107.00107_bib56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0006-3223(01)01084-8","article-title":"The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects","volume":"50","author":"Benes","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archpsyc.60.4.359","article-title":"DNA fragmentation decreased in schizophrenia but not bipolar disorder","volume":"60","author":"Benes","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib58","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1523\/JNEUROSCI.16-03-01193.1996","article-title":"Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors","volume":"16","author":"Bergeron","year":"1996","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0165-6147(03)00232-3","article-title":"Dopamine receptor-interacting proteins: the Ca2+ connection in dopamine signaling","volume":"24","author":"Bergson","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.107.00107_bib60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.0.CO;2-H","article-title":"Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain","volume":"30","author":"Bernaudin","year":"2000","journal-title":"Glia"},{"key":"10.1124\/pr.107.00107_bib61","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00004647-199906000-00007","article-title":"A potential role for erythropoietin in focal permanent cerebral ischemia in mice","volume":"19","author":"Bernaudin","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/pr.107.00107_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)80510-3","article-title":"Neuronal calcium signaling","volume":"21","author":"Berridge","year":"1998","journal-title":"Neuron"},{"key":"10.1124\/pr.107.00107_bib63","doi-asserted-by":"crossref","first-page":"12564","DOI":"10.1073\/pnas.0605177103","article-title":"Neocortical neurogenesis in humans is restricted to development","volume":"103","author":"Bhardwaj","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib64","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0006-8993(01)02615-4","article-title":"Glucose-6-phosphate dehydrogenase supports the functioning of the synapses in rat cerebellar cortex","volume":"911","author":"Biagiotti","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib65","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1176\/appi.ajp.161.4.742","article-title":"Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia","volume":"161","author":"Black","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0074-7742(02)51010-2","article-title":"Glucose\/mitochondria in neurological conditions","volume":"51","author":"Blass","year":"2002","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pr.107.00107_bib67","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S1461145702002894","article-title":"The GABAergic system in schizophrenia","volume":"5","author":"Blum","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib68","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.euroneuro.2006.12.003","article-title":"Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia","volume":"17","author":"Boks","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib69","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0893-133X(02)00311-1","article-title":"SR46349-B, a 5-HT2A\/2C receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens","volume":"27","author":"Bonaccorso","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib70","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0074-7742(02)51006-0","article-title":"Insulin-like growth factor-1 promotes neuronal glucose utilization during brain development and repair processes","volume":"51","author":"Bondy","year":"2002","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pr.107.00107_bib71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-007-0845-5","article-title":"Activation of GABAB receptors reverses spontaneous gating deficits in juvenile DBA\/2J mice","volume":"194","author":"Bortolato","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cercor\/4.1.69","article-title":"The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study","volume":"4","author":"Bourdelais","year":"1994","journal-title":"Cereb Cortex"},{"key":"10.1124\/pr.107.00107_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coph.2005.10.002","article-title":"GABAB receptor: a site of therapeutic benefit","volume":"6","author":"Bowery","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pr.107.00107_bib74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib75","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archpsyc.59.8.696","article-title":"Sensory information processing in neuroleptic-naive first-episode schizophrenia patients: a functional magnetic resonance imaging study","volume":"59","author":"Braus","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2004.03.006","article-title":"Advances in protein kinase B signaling: AKTion on multiple fronts","volume":"29","author":"Brazil","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/pr.107.00107_bib77","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.1992.01820120009003","article-title":"Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures","volume":"49","author":"Breier","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib78","first-page":"1","article-title":"The neuregulin-I\/ErbB signaling system in development and disease","volume":"190","author":"Britsch","year":"2007","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"10.1124\/pr.107.00107_bib79","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury","volume":"97","author":"Brines","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0920-9964(02)00201-3","article-title":"Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex","volume":"58","author":"Broadbelt","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)00096-4","article-title":"The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors","volume":"325","author":"Brot","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib82","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.biopsych.2004.12.002","article-title":"Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions","volume":"57","author":"Browning","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/ajp.150.1.59","article-title":"Structural abnormalities in deficit and nondeficit schizophrenia","volume":"150","author":"Buchanan","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib84","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1176\/ajp.155.8.1049","article-title":"Structural evaluation of the prefrontal cortex in schizophrenia","volume":"155","author":"Buchanan","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib85","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1192\/bjp.156.2.216","article-title":"Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography","volume":"156","author":"Buchsbaum","year":"1990","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib86","first-page":"1","article-title":"Neurotrophins and schizophrenia","volume":"84","author":"Buckley","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2006.12.026","article-title":"Brain derived neurotrophic factor in first-episode psychosis","volume":"91","author":"Buckley","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib88","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.410330516","article-title":"Neuroleptic medications inhibit complex I of the electron transport chain","volume":"33","author":"Burkhardt","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1124\/pr.107.00107_bib89","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2008.02.009","article-title":"Expression of d-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia","volume":"102","author":"Burnet","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib91","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0920-9964(98)00146-7","article-title":"Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and \u03b11-adrenergic receptors in vitro","volume":"37","author":"Bymaster","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib92","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.peptides.2006.04.024","article-title":"Neurotensin: role psychiatric and neurological diseases","volume":"27","author":"C\u00e1ceda","year":"2006","journal-title":"Peptides"},{"key":"10.1124\/pr.107.00107_bib93","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archpsyc.59.11.1002","article-title":"Brain volume changes in first-episode schizophrenia: a 1-year follow-up study","volume":"59","author":"Cahn","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib94","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.0.CO;2-B","article-title":"Regulation of neurogenesis by growth factors and neurotransmitters","volume":"36","author":"Cameron","year":"1998","journal-title":"J Neurobiol"},{"key":"10.1124\/pr.107.00107_bib95","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archpsyc.55.12.1084","article-title":"Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls","volume":"55","author":"Cannon","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib96","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia\u2014implications for schizophrenia and Parkinson\u2019s disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1124\/pr.107.00107_bib97","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbamem.2006.09.025","article-title":"G protein-coupled receptors in major psychiatric disorders","volume":"1768","author":"Catapano","year":"2007","journal-title":"Biochem Biophys Acta"},{"key":"10.1124\/pr.107.00107_bib98","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/10715769109145832","article-title":"Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer\u2019s disease brains","volume":"12\u201313","author":"Ceballos","year":"1991","journal-title":"Free Radic Res Commun"},{"key":"10.1124\/pr.107.00107_bib99","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00702-005-0432-z","article-title":"Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain","volume":"113","author":"Ceresoli-Borroni","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1124\/pr.107.00107_bib100","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2174\/138945006778019309","article-title":"Tachykinins and neuropsychiatric disorders","volume":"7","author":"Chahl","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1124\/pr.107.00107_bib101","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(95)90441-7","article-title":"Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine","volume":"345","author":"Chakos","year":"1995","journal-title":"Lancet"},{"key":"10.1124\/pr.107.00107_bib102","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.151.10.1430","article-title":"Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs","volume":"151","author":"Chakos","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib103","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0006-3223(98)00029-8","article-title":"Striatal enlargement in rats chronically treated with neuroleptic","volume":"44","author":"Chakos","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib104","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1523\/JNEUROSCI.03-08-01607.1983","article-title":"Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons","volume":"3","author":"Chiodo","year":"1983","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-8993(02)03215-8","article-title":"Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration","volume":"954","author":"Chlan-Fourney","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib106","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pscychresns.2003.08.002","article-title":"State-related changes in cerebral white matter may underlie psychosis exacerbation","volume":"130","author":"Christensen","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2004.07.009","article-title":"Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism","volume":"1023","author":"Chung","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib108","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1471-4159.2002.00857.x","article-title":"Akt pathway mediates a cGMP-dependent survival role of nitric oxide in cerebellar granule neurones","volume":"81","author":"Ciani","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib109","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2826.2004.01121.x","article-title":"Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo","volume":"16","author":"Ciriza","year":"2004","journal-title":"J Neuroendocrinol"},{"key":"10.1124\/pr.107.00107_bib110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.schres.2003.09.017","article-title":"Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities","volume":"69","author":"Clinton","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib111","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1073\/pnas.95.8.4678","article-title":"Dehydroepiandrosterone: a potential signaling molecule for neocortical organization during development","volume":"95","author":"Compagnone","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0925-4927(01)00097-X","article-title":"Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia","volume":"107","author":"Convit","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib113","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02246146","article-title":"Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonist-induced behaviors","volume":"120","author":"Corbett","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib114","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1176\/ajp.156.8.1200","article-title":"Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics","volume":"156","author":"Corson","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229609017192","article-title":"The glutamatergic dysfunction hypothesis for schizophrenia","volume":"3","author":"Coyle","year":"1996","journal-title":"Harv Rev Psychiatry"},{"key":"10.1124\/pr.107.00107_bib116","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.1124\/pr.107.00107_bib117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/scbi.1995.0005","article-title":"The Bcl-2 gene family","volume":"6","author":"Craig","year":"1995","journal-title":"Semin Cancer Biol"},{"key":"10.1124\/pr.107.00107_bib118","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0006-8993(86)91500-3","article-title":"Anxiolytic activity of an endogenous adrenal steroid","volume":"398","author":"Crawley","year":"1986","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib119","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.8.2.223","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"8","author":"Creese","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1124\/pr.107.00107_bib120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/oxfordjournals.schbul.a033323","article-title":"Limbic-cortical neuronal damage and the pathophysiology of schizophrenia","volume":"24","author":"Csernansky","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1124\/pr.107.00107_bib121","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pbb.2006.01.009","article-title":"Neuroprotective effects of olanzapine in a rat model of neurodevelopmental injury","volume":"83","author":"Csernansky","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib122","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","article-title":"NMDA receptor subunits: diversity, development and disease","volume":"11","author":"Cull-Candy","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"10.1124\/pr.107.00107_bib123","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000077368","article-title":"Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics","volume":"49","author":"Dakhale","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1124\/pr.107.00107_bib124","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3940(93)90483-2","article-title":"Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats","volume":"152","author":"Daly","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib125","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0006-3223(97)00553-2","article-title":"Ventricular enlargement in poor-outcome schizophrenia","volume":"43","author":"Davis","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib126","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archpsyc.60.5.443","article-title":"White matter changes in schizophrenia: evidence for myelin-related dysfunction","volume":"60","author":"Davis","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib127","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s007020050061","article-title":"Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus","volume":"105","author":"Dawirs","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1124\/pr.107.00107_bib128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/1098-2396(20010101)39:1<70::AID-SYN10>3.0.CO;2-J","article-title":"Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment","volume":"39","author":"Dawson","year":"2001","journal-title":"Synapse"},{"issue":"Suppl","key":"10.1124\/pr.107.00107_bib129","first-page":"S33","article-title":"Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-d-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors","volume":"150","author":"Debonnel","year":"1996","journal-title":"J Endocrinol"},{"key":"10.1124\/pr.107.00107_bib130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3940(88)90597-6","article-title":"Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer\u2019s disease","volume":"92","author":"Delacourte","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0925-4927(97)00012-7","article-title":"Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia","volume":"74","author":"DeLisi","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib132","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00221-005-0290-9","article-title":"Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia","volume":"168","author":"Deng","year":"2006","journal-title":"Exp Brain Res"},{"key":"10.1124\/pr.107.00107_bib133","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/schbul\/sbm096","article-title":"The orexins\/hypocretins and schizophrenia","volume":"33","author":"Deutch","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1124\/pr.107.00107_bib134","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0306-4522(95)00357-6","article-title":"The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization","volume":"70","author":"Deutch","year":"1996","journal-title":"Neuroscience"},{"key":"10.1124\/pr.107.00107_bib135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1098-2396(199607)23:3<182::AID-SYN7>3.0.CO;2-4","article-title":"Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate","volume":"23","author":"Deutch","year":"1996","journal-title":"Synapse"},{"key":"10.1124\/pr.107.00107_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-198902000-00001","article-title":"A \u201cglutamatergic hypothesis\u201d of schizophrenia: rationale for pharmacotherapy with glycine","volume":"12","author":"Deutsch","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/pr.107.00107_bib137","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00002826-200101000-00008","article-title":"A revised excitotoxic hypothesis of schizophrenia: therapeutic implications","volume":"24","author":"Deutsch","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/pr.107.00107_bib138","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1530-0277.1995.tb01514.x","article-title":"The neurosteroid, 3\u03b1-hydroxy-5\u03b1-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats","volume":"19","author":"Devaud","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/pr.107.00107_bib139","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/09537100500128872","article-title":"Oxidative stress in blood platelets from schizophrenic patients","volume":"16","author":"Dietrich-Muszalska","year":"2005","journal-title":"Platelets"},{"key":"10.1124\/pr.107.00107_bib140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jpsychires.2004.08.005","article-title":"Plasma dehydroepiandrosterone levels are strongly increased in schizophrenia","volume":"39","author":"di Michele","year":"2005","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pr.107.00107_bib141","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.107.00107_bib142","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2003.09.023","article-title":"Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex","volume":"123","author":"Djebaili","year":"2004","journal-title":"Neuroscience"},{"key":"10.1124\/pr.107.00107_bib143","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.107.00107_bib144","doi-asserted-by":"crossref","first-page":"R867","DOI":"10.1152\/ajpregu.00533.2002","article-title":"Fibroblast growth factors as regulators of central nervous system development and function","volume":"284","author":"Dono","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/pr.107.00107_bib145","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.275.5300.661","article-title":"Regulation of neuronal survival by the serine-threonine protein kinase Akt","volume":"275","author":"Dudek","year":"1997","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib146","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2004.02.033","article-title":"Depression: a case of neuronal life and death?","volume":"56","author":"Duman","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib147","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-8993(98)00926-3","article-title":"Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation","volume":"812","author":"Duncan","year":"1998","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib148","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-8993(99)01776-X","article-title":"Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine","volume":"843","author":"Duncan","year":"1999","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib149","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(24)39197-9","article-title":"Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism","volume":"293","author":"Duncan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(97)01390-5","article-title":"Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia","volume":"787","author":"Duncan","year":"1998","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib151","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0920-9964(00)00084-0","article-title":"Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses","volume":"52","author":"Durany","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib152","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.301.1.197","article-title":"Differential effects of haloperidol and clozapine on [3H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain","volume":"301","author":"Dwivedi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib153","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/(SICI)1097-4652(199901)178:1<93::AID-JCP12>3.0.CO;2-U","article-title":"An ethanol-sensitive variant of the PC12 neuronal cell line: sensitivity to alcohol is associated with increased cell adhesion and decreased glucose accumulation","volume":"178","author":"Dwyer","year":"1999","journal-title":"J Cell Physiol"},{"key":"10.1124\/pr.107.00107_bib154","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0074-7742(02)51015-1","article-title":"Psychoactive drugs affect glucose transport and the regulation of glucose metabolism","volume":"51","author":"Dwyer","year":"2002","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pr.107.00107_bib155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0074-7742(06)77008-8","article-title":"Neuroprotection and enhancement of neurite outgrowth with small molecular weight compounds from screens of chemical libraries","volume":"77","author":"Dwyer","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pr.107.00107_bib156","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0006-8993(03)02351-5","article-title":"Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism","volume":"971","author":"Dwyer","year":"2003","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib157","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1586\/14737175.3.1.29","article-title":"Neuronal glucose metabolism and schizophrenia: therapeutic prospects?","volume":"3","author":"Dwyer","year":"2003","journal-title":"Expert Rev Neurother"},{"key":"10.1124\/pr.107.00107_bib158","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0278-5846(98)00092-X","article-title":"Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells","volume":"23","author":"Dwyer","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib159","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2174\/156802607782341037","article-title":"Relevance of neuropeptide Y (NPY) in psychiatry","volume":"7","author":"Eaton","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/pr.107.00107_bib160","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1523\/JNEUROSCI.23-19-07311.2003","article-title":"The role of the extracellular signal-regulated kinase signaling pathway in mood modulation","volume":"23","author":"Einat","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib161","first-page":"168","article-title":"Genetics of schizophrenia: recent advances","volume":"40","author":"Eisener","year":"2007","journal-title":"Psychopharmacol Bull"},{"key":"10.1124\/pr.107.00107_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(93)90036-D","article-title":"Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs","volume":"57","author":"Ellenbroek","year":"1993","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.107.00107_bib163","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00187254","article-title":"The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs","volume":"93","author":"Ellenbroek","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib164","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nat Genet"},{"key":"10.1124\/pr.107.00107_bib165","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1523\/JNEUROSCI.4650-03.2004","article-title":"Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with schizophrenia","volume":"24","author":"Emamian","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib166","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.physbeh.2007.05.025","article-title":"The kynurenic acid hypothesis of schizophrenia","volume":"92","author":"Erhardt","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.107.00107_bib167","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/BF01291892","article-title":"Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics","volume":"104","author":"Evins","year":"1997","journal-title":"J Neural Transm"},{"key":"10.1124\/pr.107.00107_bib168","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0920-9964(96)00024-2","article-title":"Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity","volume":"21","author":"Farber","year":"1996","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib169","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0893-133X(97)00127-9","article-title":"Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity","volume":"18","author":"Farber","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-3223(93)90265-F","article-title":"Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity","volume":"34","author":"Farber","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib171","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0006-3223(95)00046-1","article-title":"Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?","volume":"38","author":"Farber","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib172","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/S0014-2999(98)00285-4","article-title":"Clozapine and olanzapine treatment decreases rat cortical and limbic GABAA receptors","volume":"349","author":"Farnbach-Pralong","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib173","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0006-3223(98)00207-8","article-title":"Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic\/schizoaffective patients","volume":"45","author":"Faustman","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib174","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.nbd.2006.01.015","article-title":"Alterations of white matter connectivity in first episode schizophrenia","volume":"22","author":"Federspiel","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pr.107.00107_bib175","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1073\/pnas.89.5.1567","article-title":"Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it","volume":"89","author":"Flood","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib176","doi-asserted-by":"crossref","first-page":"10806","DOI":"10.1073\/pnas.92.23.10806","article-title":"Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive","volume":"92","author":"Flood","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib177","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/schbul\/sbm062","article-title":"Neural synchrony in schizophrenia: from networks to new treatments","volume":"33","author":"Ford","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1124\/pr.107.00107_bib178","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(87)90485-9","article-title":"GABAergic supersensitivity within the pars reticulata of the rat substantia nigra following chronic haloperidol administration","volume":"425","author":"Frey","year":"1987","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib179","first-page":"61","article-title":"Superoxide dismutases","volume":"58","author":"Fridovich","year":"1986","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"10.1124\/pr.107.00107_bib180","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0006-3223(99)00232-2","article-title":"The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer\u2019s disease","volume":"46","author":"Friedman","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00235-1","article-title":"Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine","volume":"398","author":"Fujimura","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib182","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jnr.10733","article-title":"Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus","volume":"74","author":"Fumagalli","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib183","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/mol.107.043786","article-title":"Dynamic regulation of glutamatergic post-synaptic activity in rat prefrontal cortex by repeated administration antipsychotic drugs","volume":"73","author":"Fumagalli","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.107.00107_bib184","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00001756-200409150-00022","article-title":"Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801","volume":"15","author":"Fumagalli","year":"2004","journal-title":"Neuroreport"},{"key":"10.1124\/pr.107.00107_bib185","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jnr.10609","article-title":"Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-d-aspartate receptor activity","volume":"72","author":"Fumagalli","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib186","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.physbeh.2007.05.034","article-title":"Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function","volume":"92","author":"Fuxe","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.107.00107_bib187","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/283569a0","article-title":"Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra","volume":"283","author":"Gale","year":"1980","journal-title":"Nature"},{"key":"10.1124\/pr.107.00107_bib188","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0893-133X(98)00039-6","article-title":"Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol","volume":"19","author":"Gao","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib189","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp.65.4.446","article-title":"Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia","volume":"65","author":"Garey","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/pr.107.00107_bib190","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0006-3223(85)90038-1","article-title":"Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls","volume":"20","author":"Gattaz","year":"1985","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib191","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0006-3223(94)91139-8","article-title":"CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI","volume":"35","author":"George","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib192","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2006.08.008","article-title":"Metabotropic glutamate receptors: intracellular signaling pathways","volume":"7","author":"Gerber","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pr.107.00107_bib193","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib194","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib195","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1471-4159.2003.01881.x","article-title":"Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum","volume":"86","author":"Ghoumari","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib196","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.expneurol.2005.01.009","article-title":"Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia","volume":"193","author":"Gibson","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1124\/pr.107.00107_bib197","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archneur.61.5.641","article-title":"The neurobiology of dopamine signaling","volume":"61","author":"Girault","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1124\/pr.107.00107_bib198","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2008.40","article-title":"Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway","author":"Girgis","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib199","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.schres.2005.08.014","article-title":"Apoptotic mechanisms and the synaptic pathology of schizophrenia","volume":"81","author":"Glantz","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","article-title":"Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia","volume":"57","author":"Glantz","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib201","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002130050165","article-title":"Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice","volume":"129","author":"Gleason","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib202","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0006-3223(01)01321-X","article-title":"Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine","volume":"51","author":"Goff","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib203","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1176\/ajp.152.12.1730","article-title":"Tardive dyskinesia and substrates of energy metabolism in CSF","volume":"152","author":"Goff","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib204","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-004-1793-y","article-title":"Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction","volume":"174","author":"Goldman-Rakic","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02244924","article-title":"Seroquel: electrophysiological profile of a potential atypical antipsychotic","volume":"112","author":"Goldstein","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib206","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1074\/jbc.271.1.192","article-title":"The oxidative metabolism of glutamine. A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells","volume":"271","author":"Goossens","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.107.00107_bib207","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s002130050527","article-title":"Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats","volume":"135","author":"Goudie","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1124\/pr.107.00107_bib208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0091-3057(99)00079-9","article-title":"Discriminative stimulus properties of antipsychotics","volume":"64","author":"Goudie","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib209","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00008877-199812000-00006","article-title":"Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands","volume":"9","author":"Goudie","year":"1998","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.107.00107_bib210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/6365","article-title":"Learning enhances adult neurogenesis in the hippocampal formation","volume":"2","author":"Gould","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.107.00107_bib211","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.npp.1300731","article-title":"Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs","volume":"30","author":"Gould","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib212","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainres.2005.11.047","article-title":"Treatment with olanzapine increases cell proliferation in the subventricular zone and prefrontal cortex","volume":"1070","author":"Green","year":"2006","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib213","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1471-4159.1995.64010430.x","article-title":"Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate","volume":"64","author":"Greene","year":"1995","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib214","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0301-0082(96)00006-8","article-title":"Bioenergetics and glutamate excitotoxicity","volume":"48","author":"Greene","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1124\/pr.107.00107_bib215","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hipo.1072","article-title":"Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia","volume":"11","author":"Greene","year":"2001","journal-title":"Hippocampus"},{"key":"10.1124\/pr.107.00107_bib216","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm1073","article-title":"Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone","volume":"10","author":"Griffin","year":"2004","journal-title":"Nat Med"},{"key":"10.1124\/pr.107.00107_bib217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)01917-4","article-title":"Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: the roles of glutamate, dopamine, acetylcholine and corticosteroids","volume":"855","author":"Griffiths","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib218","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychires.2006.01.005","article-title":"Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics","volume":"41","author":"Grillo","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pr.107.00107_bib219","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00001756-199902250-00004","article-title":"NR2-B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia","volume":"10","author":"Grimwood","year":"1999","journal-title":"Neuroreport"},{"key":"10.1124\/pr.107.00107_bib220","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1093\/emboj\/17.14.3878","article-title":"Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis","volume":"17","author":"Gross","year":"1998","journal-title":"EMBO J"},{"key":"10.1124\/pr.107.00107_bib221","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1523\/JNEUROSCI.16-06-02034.1996","article-title":"NMDA-dependent modulation of CA1 local circuit inhibition","volume":"16","author":"Grunze","year":"1996","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib222","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-005-2212-8","article-title":"GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon","volume":"180","author":"Guidotti","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(06)78001-1","article-title":"Neurobiology of dopamine in schizophrenia","volume":"78","author":"Guillin","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pr.107.00107_bib224","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.1460-9568.2002.02256.x","article-title":"Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures","volume":"16","author":"Guo","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.107.00107_bib225","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1176\/ajp.155.12.1711","article-title":"Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia","volume":"155","author":"Gur","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib226","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archpsyc.1987.01800140021003","article-title":"Regional brain function in schizophrenia. I. A positron emission tomography study","volume":"44","author":"Gur","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib227","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(01)02242-6","article-title":"Protein kinase B (PKB\/Akt)\u2014a key regulator of glucose transport?","volume":"492","author":"Hajduch","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.107.00107_bib228","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tips.2006.05.005","article-title":"Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery","volume":"27","author":"Haj\u00f3s","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.107.00107_bib229","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1073\/pnas.081071198","article-title":"Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia","volume":"98","author":"Hakak","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib230","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.npp.1300422","article-title":"Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus","volume":"29","author":"Halim","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib231","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0024-3205(87)90341-9","article-title":"[3H]Muscimol binding sites increased in autopsied brains of chronic schizophrenics","volume":"40","author":"Hanada","year":"1987","journal-title":"Life Sci"},{"key":"10.1124\/pr.107.00107_bib232","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/15622970109027500","article-title":"Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients","volume":"2","author":"Harris","year":"2001","journal-title":"World J Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib233","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/122.4.593","article-title":"The neuropathology of schizophrenia. A critical review of the data and their interpretation","volume":"122","author":"Harrison","year":"1999","journal-title":"Brain"},{"key":"10.1124\/pr.107.00107_bib234","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.pnpbp.2005.04.023","article-title":"Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug na\u00efve schizophrenic patients","volume":"29","author":"Hashimoto","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib235","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib236","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1176\/appi.ajp.2007.07081223","article-title":"Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia","volume":"165","author":"Hashimoto","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib237","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2004.05.060","article-title":"Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease in rats","volume":"1018","author":"He","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib238","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbr.2004.11.028","article-title":"Chronic administration of quetiapine alleviates the anxiety-like behavioral changes induced by a neurotoxic regimen of dl-amphetamine in rats","volume":"160","author":"He","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1124\/pr.107.00107_bib239","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s007020100018","article-title":"Spatial memory deficit and neurodegeneration induced by the direct injection of okadaic acid into the hippocampus in rats","volume":"108","author":"He","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1124\/pr.107.00107_bib240","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/sj.npp.1300757","article-title":"Olanzapine attenuates the okadaic acid-induced spatial memory impairment and hippocampal cell death in rats","volume":"30","author":"He","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib241","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.npp.1395198","article-title":"AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics","volume":"19","author":"Healy","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib242","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0006-3223(91)90091-Y","article-title":"Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study","volume":"29","author":"Heckers","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib243","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.286.5437.105","article-title":"Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade","volume":"286","author":"Hertel","year":"1999","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib244","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02245607","article-title":"Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain","volume":"124","author":"Hertel","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib245","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.60.6.585","article-title":"Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia","volume":"60","author":"Ho","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib246","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0925-4927(95)02729-H","article-title":"Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study","volume":"61","author":"Hokama","year":"1995","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib247","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib248","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/archpsyc.61.7.658","article-title":"Pathways that make voices: white matter changes in auditory hallucinations","volume":"61","author":"Hubl","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib249","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/syn.20250","article-title":"Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia","volume":"59","author":"Huerta","year":"2006","journal-title":"Synapse"},{"key":"10.1124\/pr.107.00107_bib250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0091-3057(83)90039-4","article-title":"The effects of chronic haloperidol administration on GABA receptor binding","volume":"19","author":"Huffman","year":"1983","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-3806(02)00344-9","article-title":"Immediate and delayed hippocampal neuronal loss induced by kainic acid during early postnatal development in the rat","volume":"137","author":"Humphrey","year":"2002","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1124\/pr.107.00107_bib252","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0301-0082(96)00011-1","article-title":"The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs","volume":"49","author":"Hutchinson","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1124\/pr.107.00107_bib253","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2003.09.002","article-title":"Steroids and the reversal of age-associated changes in myelination and remyelination","volume":"71","author":"Ibanez","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1124\/pr.107.00107_bib254","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0893-133X(01)00312-8","article-title":"Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum","volume":"26","author":"Ichikawa","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib255","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib256","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(98)00308-2","article-title":"Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens","volume":"351","author":"Ichikawa","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib257","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1006\/bbrc.1998.8177","article-title":"Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites","volume":"243","author":"Imamura","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.107.00107_bib258","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0447.1974.tb09707.x","article-title":"Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia","volume":"50","author":"Ingvar","year":"1974","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/pr.107.00107_bib259","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1476-5381.1990.tb14091.x","article-title":"Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats","volume":"100","author":"Invernizzi","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib260","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0022-3565(25)23814-9","article-title":"Steroid potentiation and inhibition of N-methyl-d-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies","volume":"271","author":"Irwin","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib261","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0006-3223(92)90043-Y","article-title":"NMDA-associated glycine binding site increases in schizophrenic brains","volume":"32","author":"Ishimaru","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib262","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/hmg\/ddi022","article-title":"Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis","volume":"14","author":"Iwamoto","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.107.00107_bib263","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0006-3223(00)00988-4","article-title":"Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia","volume":"48","author":"Jarskog","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib264","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.pnpbp.2005.03.010","article-title":"Apoptic mechanisms in the pathophysiology of schizophrenia","volume":"29","author":"Jarskog","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1176\/appi.ajp.161.1.109","article-title":"Apoptotic proteins in the temporal cortex in schizophrenia: high Bax\/Bcl-2 ratio without caspase-3 activation","volume":"161","author":"Jarskog","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib266","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib267","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0893-133X(98)00004-9","article-title":"Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion","volume":"19","author":"Jentsch","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib268","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-8993(96)00605-1","article-title":"Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats","volume":"735","author":"Jiang","year":"1996","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib269","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.neulet.2006.02.056","article-title":"Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse","volume":"400","author":"Jockers-Scher\u00fcbl","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib270","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/neu.1995.12.843","article-title":"Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury","volume":"12","author":"Johnson","year":"1995","journal-title":"J Neurotrauma"},{"key":"10.1124\/pr.107.00107_bib271","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/325529a0","article-title":"Glycine potentiates the NMDA response in cultured mouse brain neurons","volume":"325","author":"Johnson","year":"1987","journal-title":"Nature"},{"key":"10.1124\/pr.107.00107_bib272","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/(SICI)1097-4547(19980615)52:6<709::AID-JNR10>3.0.CO;2-U","article-title":"Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex","volume":"52","author":"Johnson","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib273","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib274","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2003.10.025","article-title":"In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function","volume":"483","author":"Jordan","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib275","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pharmthera.2005.10.014","article-title":"The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia","volume":"110","author":"Kalkman","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.107.00107_bib276","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1097\/00001756-200011090-00044","article-title":"The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients","volume":"11","author":"Kalus","year":"2000","journal-title":"Neuroreport"},{"key":"10.1124\/pr.107.00107_bib277","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1084\/jem.180.3.917","article-title":"Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line","volume":"180","author":"Kan","year":"1994","journal-title":"J Exp Med"},{"key":"10.1124\/pr.107.00107_bib278","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3940(99)00610-2","article-title":"Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins","volume":"273","author":"Kaplan","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib279","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib280","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib281","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","article-title":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine","volume":"104","author":"Kargieman","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib282","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.biopsych.2003.12.012","article-title":"Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study","volume":"55","author":"Karry","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib283","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1176\/appi.ajp.160.1.156","article-title":"Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia","volume":"160","author":"Kasai","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib284","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0006-3223(91)90025-H","article-title":"Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle","volume":"30","author":"Keith","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib285","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0091-3057(96)00342-5","article-title":"The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats","volume":"57","author":"Kelley","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib286","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(94)90599-1","article-title":"Changes in caudate volume with neuroleptic treatment","volume":"344","author":"Keshavan","year":"1994","journal-title":"Lancet"},{"key":"10.1124\/pr.107.00107_bib287","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(00)02373-8","article-title":"Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in mice","volume":"865","author":"Khisti","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib288","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","article-title":"Antidepressant-like effect of the neurosteroid 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in mice forced swim test","volume":"67","author":"Khisti","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib289","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0304-3940(80)90178-0","article-title":"Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia","volume":"20","author":"Kim","year":"1980","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib290","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1523\/JNEUROSCI.1120-05.2005","article-title":"Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs","volume":"25","author":"Kippin","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib291","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biopsych.2004.07.008","article-title":"Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat","volume":"56","author":"Kodama","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib292","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0028-3908(96)00021-4","article-title":"Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice","volume":"35","author":"Kokate","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.107.00107_bib293","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-3565(25)22531-9","article-title":"Anticonvulsant activity of neurosteroids: correlation with \u03b3-aminobutyric acid-evoked chloride current potentiation","volume":"270","author":"Kokate","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib294","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1176\/appi.ajp.162.6.1200","article-title":"Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia","volume":"162","author":"Kolluri","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib295","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1073\/pnas.90.15.7005","article-title":"The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum","volume":"90","author":"Konradi","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib296","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0165-1781(87)90095-3","article-title":"Cerebrospinal fluid amino acid concentrations in chronic schizophrenia","volume":"20","author":"Korpi","year":"1987","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib297","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S1461145705006097","article-title":"Psychotropic drugs affect Ser9-phosphorylated GSK-3\u03b2 protein levels in rodent frontal cortex","volume":"9","author":"Kozlovsky","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib298","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/appi.ajp.157.5.831","article-title":"Low GSK-3\u03b2 immunoreactivity in postmortem frontal cortex of schizophrenic patients","volume":"157","author":"Kozlovsky","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib299","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(00)00174-2","article-title":"Low GSK-3 activity in frontal cortex of schizophrenic patients","volume":"52","author":"Kozlovsky","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib300","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00702-004-0166-3","article-title":"Reduced GSK-3\u03b2 mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients","volume":"111","author":"Kozlovsky","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1124\/pr.107.00107_bib301","doi-asserted-by":"crossref","first-page":"14190","DOI":"10.1523\/JNEUROSCI.4229-07.2007","article-title":"The impact of catechol-O-methyltransferase and dopamine D4 receptor genotypes on neurophysiological markers of performance monitoring","volume":"27","author":"Kr\u00e4mer","year":"2007","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib302","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/jnp.17.2.227","article-title":"Oxidative stress during treatment with first- and second-generation antipsychotics","volume":"17","author":"Kropp","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1124\/pr.107.00107_bib303","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-#","article-title":"Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study","volume":"31","author":"Kung","year":"1999","journal-title":"Synapse"},{"key":"10.1124\/pr.107.00107_bib304","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00001756-200105080-00025","article-title":"Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells","volume":"12","author":"K\u00fcppers","year":"2001","journal-title":"Neuroreport"},{"key":"10.1124\/pr.107.00107_bib305","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3565(24)38019-X","article-title":"Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens","volume":"288","author":"Kuroki","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib306","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1471-4159.1992.tb08320.x","article-title":"\u03b1-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics","volume":"59","author":"Kurumaji","year":"1992","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib307","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0006-8993(89)91074-3","article-title":"Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use","volume":"496","author":"Kurumaji","year":"1989","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib308","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0074-7742(04)59008-6","article-title":"Mitogen-activated protein kinase signaling","volume":"59","author":"Kyosseva","year":"2004","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/pr.107.00107_bib309","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0006-3223(99)00104-3","article-title":"Mitogen-activated protein kinases in schizophrenia","volume":"46","author":"Kyosseva","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib311","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib312","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000110430","article-title":"Molecular mechanisms of schizophrenia","volume":"20","author":"Lang","year":"2007","journal-title":"Cell Physiol Biochem"},{"key":"10.1124\/pr.107.00107_bib313","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.09.009","article-title":"Muscarinic acetylcholine receptors as CNS drug targets","volume":"117","author":"Langmead","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.107.00107_bib314","first-page":"211","article-title":"Imaging dopamine transmission in schizophrenia. A review and meta-analysis","volume":"42","author":"Laruelle","year":"1998","journal-title":"Q J Nucl Med"},{"key":"10.1124\/pr.107.00107_bib315","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1242\/jcs.114.16.2903","article-title":"PKB\/Akt: a key mediator of cell proliferation, survival and insulin responses?","volume":"114","author":"Lawlor","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1124\/pr.107.00107_bib316","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.npp.1301511","article-title":"The role of Akt-GSK-3\u03b2 signaling and synaptic strength in phencyclidine-induced neurodegeneration","volume":"33","author":"Lei","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib317","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1523\/JNEUROSCI.20-11-04011.2000","article-title":"Intracellular modulation of NMDA receptor function by antipsychotic drugs","volume":"20","author":"Leveque","year":"2000","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib318","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.3306916","article-title":"The nerve growth factor 35 years later","volume":"237","author":"Levi-Montalcini","year":"1987","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib319","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bcp.2007.07.019","article-title":"Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function","volume":"74","author":"Levin","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.107.00107_bib320","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10673220701650409","article-title":"Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions","volume":"15","author":"Lewandowski","year":"2007","journal-title":"Harv Rev Psychiatry"},{"key":"10.1124\/pr.107.00107_bib321","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0165-0173(99)00042-9","article-title":"GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia","volume":"31","author":"Lewis","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1124\/pr.107.00107_bib322","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-003-1673-x","article-title":"Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction","volume":"174","author":"Lewis","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib323","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1192\/bjp.bp.107.037218","article-title":"CATIE and CUtLASS: can we handle the truth?","volume":"192","author":"Lewis","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib324","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1523\/JNEUROSCI.22-08-03070.2002","article-title":"NMDA receptor antagonists disinhibit rat posterior cingulated and retrosplenial cortices: a potential mechanism of neurotoxicity","volume":"22","author":"Li","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1461145706006547","article-title":"Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics","volume":"10","author":"Li","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib326","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-4547(19990401)56:1<72::AID-JNR9>3.0.CO;2-0","article-title":"Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor","volume":"56","author":"Li","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib327","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002130050551","article-title":"Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum","volume":"136","author":"Li","year":"1998","journal-title":"Psychopharmacoloy (Berl)"},{"key":"10.1124\/pr.107.00107_bib328","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/sj.npp.1300768","article-title":"N-Desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors","volume":"30","author":"Li","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib329","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","article-title":"Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain","volume":"493","author":"Li","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib330","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-0173(03)00203-0","article-title":"Calcium signaling dysfunction in schizophrenia: a unifying approach","volume":"43","author":"Lidow","year":"2003","journal-title":"Brain Res Rev"},{"key":"10.1124\/pr.107.00107_bib331","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-3223(01)01067-8","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"Lieberman","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib332","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1993.01820170047006","article-title":"Time course and biologic correlates of treatment response in first-episode schizophrenia","volume":"50","author":"Lieberman","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib333","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0006-3223(99)00147-X","article-title":"Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective","volume":"46","author":"Lieberman","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib334","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","article-title":"The early stages of schizophrenia: speculations on pathogenesis, pathophysiology and therapeutic approaches","volume":"50","author":"Lieberman","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"Suppl","key":"10.1124\/pr.107.00107_bib335","first-page":"1","article-title":"Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection","volume":"11","author":"Lieberman","year":"2006","journal-title":"CNS Spectr"},{"key":"10.1124\/pr.107.00107_bib336","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.107.00107_bib337","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib338","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(02)02620-3","article-title":"5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner","volume":"947","author":"Li\u00e9geois","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib339","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00213-003-1533-8","article-title":"Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys","volume":"169","author":"Linn","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib340","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1460-9568.2001.01633.x","article-title":"BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs","volume":"14","author":"Lipska","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.107.00107_bib341","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(02)00448-2","article-title":"Allopregnanolone attenuates N-methyl-d-aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture","volume":"328","author":"Lockhart","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib342","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.npp.1301356","article-title":"Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat","volume":"32","author":"L\u00f3pez-Gil","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib343","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"key":"10.1124\/pr.107.00107_bib344","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tins.2007.02.002","article-title":"Schizophrenia as a GSK-3 dysregulation disorder","volume":"30","author":"Lovestone","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1124\/pr.107.00107_bib345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2004.03.018","article-title":"Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt\/PKB, ERK1\/2 and the mitogenactivated protein kinase p38","volume":"1011","author":"Lu","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib346","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/JMN:27:1:043","article-title":"Second generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K\/AKT, ERK, and pertussis toxin-sensitive pathways","volume":"27","author":"Lu","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1124\/pr.107.00107_bib347","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2004.06.089","article-title":"Post-stress changes in BDNF and Bcl-2 immunoreactivities in hippocampal neurons: effect of chronic administration of olanzapine","volume":"1025","author":"Luo","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib348","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-1781(90)90136-S","article-title":"Amino acid patterns in schizophrenia: some new findings","volume":"32","author":"Macciardi","year":"1990","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib349","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2008.02.002","article-title":"Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia","volume":"101","author":"Madeira","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib350","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0006-3223(00)00228-6","article-title":"Increased neurogenesis in a model of electroconvulsive therapy","volume":"47","author":"Madsen","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib351","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(90)90261-9","article-title":"The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor","volume":"526","author":"Majewska","year":"1990","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib352","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib353","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0304-3940(88)90202-9","article-title":"Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons","volume":"90","author":"Majewska","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib354","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib355","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhotra","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib356","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0091-3057(01)00561-5","article-title":"Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone","volume":"69","author":"Mansbach","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib357","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.biopsych.2004.02.003","article-title":"Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain","volume":"55","author":"Maragnoli","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib358","first-page":"153","article-title":"Are there differences in serum cholesterol and cortisol concentrations between violent and non-violent schizophrenic male suicide attempters?","volume":"29","author":"Marcinko","year":"2005","journal-title":"Coll Antropol"},{"key":"10.1124\/pr.107.00107_bib359","first-page":"161","article-title":"Cholesterol serum levels in violent and non-violent young male schizophrenic suicide attempters","volume":"16","author":"Marcinko","year":"2004","journal-title":"Psychiatr Danub"},{"key":"10.1124\/pr.107.00107_bib360","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psychres.2006.08.012","article-title":"Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis","volume":"150","author":"Marcinko","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib361","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1242\/jeb.01049","article-title":"Erythropoietin and the hypoxic brain","volume":"207","author":"Marti","year":"2004","journal-title":"J Exp Biol"},{"key":"10.1124\/pr.107.00107_bib362","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1097\/00001756-199809140-00012","article-title":"Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats","volume":"9","author":"Martin","year":"1998","journal-title":"Neuroreport"},{"key":"10.1124\/pr.107.00107_bib363","series-title":"Handbook of Stress and the Brain","first-page":"301","article-title":"Atypical antipsychotics and stress","author":"Marx","year":"2005"},{"key":"10.1124\/pr.107.00107_bib364","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0006-3223(99)00305-4","article-title":"Olanzapine increases allopregnanolone in the rat cerebral cortex","volume":"47","author":"Marx","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300015","article-title":"Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents","volume":"28","author":"Marx","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib366","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.pbb.2006.07.032","article-title":"Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib367","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib368","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.jcp.0000155818.29091.53","article-title":"Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone","volume":"25","author":"Massana","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/pr.107.00107_bib369","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00213-006-0570-5","article-title":"Lower striatal dopamine transporter binding in neuroleptic-na\u00efve schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait","volume":"191","author":"Mateos","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib370","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/archpsyc.58.2.148","article-title":"Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study","volume":"58","author":"Mathalon","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib371","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0028-3908(98)00163-4","article-title":"Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity","volume":"38","author":"Math\u00e9","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.107.00107_bib372","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.1982.04290100001001","article-title":"Regional cerebral blood flow in schizophrenia","volume":"39","author":"Mathew","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib373","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V","article-title":"\u201cApoptotic\u201d biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders","volume":"58","author":"Mattson","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib374","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/glia.20119","article-title":"Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics","volume":"49","author":"Matute","year":"2005","journal-title":"Glia"},{"key":"10.1124\/pr.107.00107_bib375","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1006872911332","article-title":"Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics","volume":"174","author":"Maurer","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/pr.107.00107_bib376","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0920-9964(00)00075-X","article-title":"Evidence for a mitochondrial oxidative phosphorylation defect in brains for patients with schizophrenia","volume":"48","author":"Maurer","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib377","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35049047","article-title":"Interneurons unbound","volume":"2","author":"McBain","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pr.107.00107_bib378","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0893-133X(01)00370-0","article-title":"Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder","volume":"26","author":"McCullumsmith","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib379","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.mehy.2005.06.022","article-title":"Impaired neuronal glucose uptake in pathogenesis of schizophrenia\u2014can GLUT 1 and GLUT 3 deficits explain imaging, postmortem and pharmacological findings?","volume":"65","author":"McDermott","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1124\/pr.107.00107_bib380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0009-2797(99)00105-2","article-title":"Induction of apoptosis by remoxipride metabolites in HL60 and CD34+\/CD19- human bone marrow progenitor cells: potential relevance to remoxipride-induced aplastic anemia","volume":"121","author":"McGuinness","year":"1999","journal-title":"Chem Biol Interact"},{"key":"10.1124\/pr.107.00107_bib381","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pnpbp.2007.10.017","article-title":"Treatment with haloperidol and diazepam alters GABAA receptor density in the rat brain","volume":"32","author":"McLeod","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib382","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/09540260701502468","article-title":"The role of dopamine for the pathophysiology of schizophrenia","volume":"19","author":"Meisenzahl","year":"2007","journal-title":"Int Rev Psychiatry"},{"key":"10.1124\/pr.107.00107_bib383","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/sj.mp.4000880","article-title":"The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine","volume":"6","author":"Melone","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib384","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib385","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr Bull"},{"key":"10.1124\/pr.107.00107_bib386","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2003.09.040","article-title":"Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum","volume":"995","author":"Meredith","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib387","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00702-004-0160-9","article-title":"Cu, Zn-, and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis","volume":"111","author":"Michel","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1124\/pr.107.00107_bib388","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157488906778773634","article-title":"Selective dopamine D3 receptor antagonists: a review 2001\u20132005","volume":"1","author":"Micheli","year":"2006","journal-title":"Recent Patents CNS Drug Discov"},{"key":"10.1124\/pr.107.00107_bib389","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0165-0173(99)00040-5","article-title":"Basal ganglia and cerebellar loops: motor and cognitive circuits","volume":"31","author":"Middleton","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1124\/pr.107.00107_bib390","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0006-3223(03)00293-2","article-title":"Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: a prospective longitudinal study with 5-year follow-up","volume":"54","author":"Milev","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib391","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00213-005-2199-1","article-title":"N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives","volume":"179","author":"Millan","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib392","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1046\/j.1460-9568.1999.00858.x","article-title":"Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat","volume":"11","author":"Millan","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.107.00107_bib393","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-3565(24)38153-4","article-title":"S-16924, a novel, potential antipsychotic with marked serotonin1A agonist properties. IV. A drug discrimination comparison with clozapine","volume":"289","author":"Millan","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib394","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-2236(00)01862-2","article-title":"Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse","volume":"24","author":"Mirnics","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1124\/pr.107.00107_bib395","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.mp.4000866","article-title":"Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia","volume":"6","author":"Mirnics","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib396","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1176\/appi.ajp.160.12.2154","article-title":"MRI assessment of gray and white matter distribution in Brodmann\u2019s areas of the cortex in patients with schizophrenia with good and poor outcomes","volume":"160","author":"Mitelman","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib397","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib398","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.euroneuro.2004.11.002","article-title":"Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders","volume":"15","author":"Miyaoka","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib399","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0278-5846(01)00247-0","article-title":"Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain","volume":"26","author":"Mizukami","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib400","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/BF02980205","article-title":"Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro","volume":"26","author":"Modica-Napolitano","year":"2003","journal-title":"Arch Pharm Res"},{"key":"10.1124\/pr.107.00107_bib401","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-004-1792-z","article-title":"Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia","volume":"174","author":"Moghaddam","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib402","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib403","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib404","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1471-4159.1990.tb01230.x","article-title":"Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study","volume":"54","author":"Moghaddam","year":"1990","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib405","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF01694546","article-title":"Heterogeneity of GABAA-receptors: cell-specific expression, pharmacology and regulation","volume":"20","author":"Mohler","year":"1995","journal-title":"Neurochem Res"},{"key":"10.1124\/pr.107.00107_bib406","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1009697908332","article-title":"Glucose transport and apoptosis","volume":"5","author":"Moley","year":"2000","journal-title":"Apoptosis"},{"key":"10.1124\/pr.107.00107_bib407","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2005.07.031","article-title":"Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia","volume":"80","author":"Molina","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib408","first-page":"281","article-title":"The pharmacology of olanzapine and other new antipsychotic agents","volume":"2","author":"Moore","year":"1993","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1124\/pr.107.00107_bib409","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-3565(25)10792-1","article-title":"The behavioral pharmacology of olanzapine, a novel \u201catypical\u201d antipsychotic agent","volume":"262","author":"Moore","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib410","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neulet.2005.03.066","article-title":"Post-ischemic administration of progesterone in rats exerts neuroprotective effects on the hippocampus","volume":"382","author":"Moral\u00ed","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib411","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coph.2004.08.008","article-title":"PCP: from pharmacology to modelling schizophrenia","volume":"5","author":"Morris","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pr.107.00107_bib412","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/cercor\/bhm186","article-title":"Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder","volume":"18","author":"Morris","year":"2008","journal-title":"Cereb Cortex"},{"key":"10.1124\/pr.107.00107_bib413","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0026-895X(25)09958-4","article-title":"Characterization of steroid interactions with \u03b3-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites","volume":"37","author":"Morrow","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.107.00107_bib414","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0014-2999(87)90094-X","article-title":"Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency","volume":"142","author":"Morrow","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuint.2007.06.019","article-title":"Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment","volume":"51","author":"Mouri","year":"2007","journal-title":"Neurochem Int"},{"key":"10.1124\/pr.107.00107_bib416","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2004.02.013","article-title":"Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss","volume":"78","author":"Moy","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib417","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molbrainres.2003.11.004","article-title":"Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia","volume":"121","author":"Mueller","year":"2004","journal-title":"Mol Brain Res"},{"key":"10.1124\/pr.107.00107_bib418","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(89)91392-5","article-title":"Family history of type 2 diabetes in schizophrenic patients","volume":"1","author":"Mukherjee","year":"1989","journal-title":"Lancet"},{"key":"10.1124\/pr.107.00107_bib419","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0925-4927(97)00013-9","article-title":"Progression of cerebroventricular enlargement and the subtyping of schizophrenia","volume":"74","author":"Nair","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib420","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/cercor\/bhh172","article-title":"Mapping cortical thickness and gray matter concentration in first episode schizophrenia","volume":"15","author":"Narr","year":"2005","journal-title":"Cereb Cortex"},{"key":"10.1124\/pr.107.00107_bib421","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1176\/appi.ajp.162.9.1738","article-title":"Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type","volume":"162","author":"Neeman","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib422","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib423","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F","article-title":"Enriched environment increases neurogenesis in the adult rat dentate gyrus and improves spatial memory","volume":"39","author":"Nilsson","year":"1999","journal-title":"J Neurobiol"},{"key":"10.1124\/pr.107.00107_bib424","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/syn.10189","article-title":"Differential effects of atypical and typical antipsychotic drugs on N-methyl-d-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex","volume":"48","author":"Ninan","year":"2003","journal-title":"Synapse"},{"key":"10.1124\/pr.107.00107_bib425","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0028-3908(03)00033-9","article-title":"Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-d-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex","volume":"44","author":"Ninan","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.107.00107_bib426","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019442-200403000-00008","article-title":"Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia","volume":"12","author":"Nishioka","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1124\/pr.107.00107_bib427","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0304-3940(83)90046-0","article-title":"Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia","volume":"40","author":"Nishikawa","year":"1983","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib428","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1098-2396(199711)27:3<168::AID-SYN2>3.0.CO;2-B","article-title":"Glutamate receptor in the postmortem striatum of schizophrenic, suicide, and control brains","volume":"27","author":"Noga","year":"1997","journal-title":"Synapse"},{"key":"10.1124\/pr.107.00107_bib429","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biopsych.2006.03.044","article-title":"Region specific regulation of NR1 in rhesus monkeys following chronic antipsychotic drug administration","volume":"60","author":"O\u2019Connor","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib430","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0024-3205(03)00321-7","article-title":"Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes","volume":"73","author":"Ohta","year":"2003","journal-title":"Life Sci"},{"key":"10.1124\/pr.107.00107_bib431","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0014-5793(92)81430-T","article-title":"Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum","volume":"313","author":"Okazawa","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.107.00107_bib432","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/385634a0","article-title":"Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET","volume":"385","author":"Okubo","year":"1997","journal-title":"Nature"},{"key":"10.1124\/pr.107.00107_bib433","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00406-002-0370-9","article-title":"Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia","volume":"252","author":"Okugawa","year":"2002","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1124\/pr.107.00107_bib434","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0893-133X(98)00048-7","article-title":"Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells","volume":"20","author":"Olianas","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib435","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib436","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pr.107.00107_bib437","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.schres.2007.06.012","article-title":"Decreased levels of plasma glutamate in patients with first episode schizophrenia and bipolar disorder","volume":"95","author":"Palomino","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib438","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-1781(97)00060-7","article-title":"Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects","volume":"71","author":"Pandey","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib439","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0022-3565(24)36626-1","article-title":"Selective action of acute systemic clozapine on acetylcholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum","volume":"281","author":"Parada","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib440","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-9964(02)00434-6","article-title":"Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome","volume":"60","author":"Parikh","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib441","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2003.10.079","article-title":"Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol","volume":"356","author":"Parikh","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib442","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpsychires.2004.03.008","article-title":"Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats","volume":"38","author":"Parikh","year":"2004","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pr.107.00107_bib443","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-003-1669-6","article-title":"Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine","volume":"172","author":"Parikh","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib444","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(99)01381-5","article-title":"Sulfated and unsulfated steroids modulate \u03b3-aminobutyric acid A receptor function through distinct sites","volume":"830","author":"Park-Chung","year":"1999","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib445","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s11064-006-9162-3","article-title":"Possible mechanisms of neurodegeneration in schizophrenia","volume":"31","author":"P\u00e9rez-Neri","year":"2006","journal-title":"Neurochem Res"},{"key":"10.1124\/pr.107.00107_bib446","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3940(82)90212-9","article-title":"Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction","volume":"28","author":"Perry","year":"1982","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib447","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00210-002-0619-x","article-title":"Differential effects of chronic haloperidol and clozapine administration on glutamatergic transmission in the fronto-parietal cortex in rats: microdialysis and electrophysiological studies","volume":"366","author":"Pietraszek","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pr.107.00107_bib448","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.schres.2006.06.017","article-title":"Differential effects of haloperidol and olanzapine on levels of vascular endothelial growth factor and angiogenesis in rat hippocampus","volume":"87","author":"Pillai","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib449","first-page":"298","article-title":"Brain-derived neurotrophic factor levels are lower in plasma as well as cerebrospinal fluid from medication-na\u00efve first episode schizophrenia patients","volume":"98","author":"Pillai","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib450","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2005.11.021","article-title":"Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus","volume":"82","author":"Pillai","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib451","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1073\/pnas.0337642100","article-title":"In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the antiaggressive action of fluoxetine","volume":"100","author":"Pinna","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib452","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pnpbp.2004.05.008","article-title":"Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment","volume":"28","author":"Pirildar","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib453","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002139900366","article-title":"Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats","volume":"149","author":"Porter","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib454","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1471-4159.2003.01851.x","article-title":"Opposite regulation by typical and atypical anti-psychotics of ERK1\/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum","volume":"86","author":"Pozzi","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib455","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib456","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0893-133X(99)00111-6","article-title":"Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics","volume":"22","author":"Prince","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib457","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)36399-2","article-title":"Neuroleptic-induced mitochondrial enzyme alterations in the rat brain","volume":"280","author":"Prince","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib458","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-977X(97)00036-9","article-title":"A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics","volume":"8","author":"Prince","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib459","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.2551039","article-title":"Type I and type II GABAA-benzodiazepine receptors produced in transfected cells","volume":"245","author":"Pritchett","year":"1989","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib460","first-page":"331","article-title":"Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment","volume":"32","author":"Procyshyn","year":"2007","journal-title":"J Psychiatry Neurosci"},{"key":"10.1124\/pr.107.00107_bib461","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pbb.2003.10.010","article-title":"Discriminative stimulus properties of 1.25 and 5.0 mg\/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms","volume":"77","author":"Prus","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib462","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/01.fbp.0000172735.73876.06","article-title":"Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg\/kg clozapine versus 5.0 mg\/kg clozapine versus vehicle in a three-choice drug discrimination task","volume":"16","author":"Prus","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pr.107.00107_bib463","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1460-9568.2003.02590.x","article-title":"The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis","volume":"17","author":"Qing","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.107.00107_bib464","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hipo.20048","article-title":"BDNF protects against stress-induced impairments in spatial learning and memory and LTP","volume":"15","author":"Radecki","year":"2005","journal-title":"Hippocampus"},{"key":"10.1124\/pr.107.00107_bib465","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.mp.4001924","article-title":"Towards a muscarinic hypothesis of schizophrenia","volume":"12","author":"Raedler","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib466","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pharmthera.2006.11.006","article-title":"Adrenergic pharmacology and cognition: focus on the prefrontal cortex","volume":"113","author":"Ramos","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.107.00107_bib467","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib468","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archpsyc.1997.01830220013002","article-title":"Childhood-onset schizophrenia. Progressive ventricular change during adolescence","volume":"54","author":"Rapoport","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib469","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.npp.1301057","article-title":"Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens","volume":"32","author":"Razoux","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib470","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0952-3278(96)90143-X","article-title":"Free radical pathology in schizophrenia: a review","volume":"55","author":"Reddy","year":"1996","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1124\/pr.107.00107_bib471","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.ejhg.5201571","article-title":"Molecular genetic studies of schizophrenia","volume":"14","author":"Riley","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1124\/pr.107.00107_bib472","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0022-3565(25)10821-5","article-title":"Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist","volume":"262","author":"Rinaldi-Carmona","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib473","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0028-3908(99)00031-3","article-title":"Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine","volume":"38","author":"Riva","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.107.00107_bib474","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0893-133X(95)00196-K","article-title":"Effects of olanzapine on regional C-Fos expression in rat forebrain","volume":"14","author":"Robertson","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib475","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(25)23800-9","article-title":"Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity","volume":"271","author":"Robertson","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib476","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/emm.2007.39","article-title":"Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex","volume":"39","author":"Roh","year":"2007","journal-title":"Exp Mol Med"},{"key":"10.1124\/pr.107.00107_bib477","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/exnr.1994.1147","article-title":"Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats","volume":"129","author":"Roof","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1124\/pr.107.00107_bib478","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0278-5846(02)00221-X","article-title":"The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats","volume":"26","author":"Rosengarten","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib479","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.expneurol.2004.01.022","article-title":"New roles for VEGF in nervous tissue\u2014beyond blood vessels","volume":"187","author":"Rosenstein","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1124\/pr.107.00107_bib480","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1073\/pnas.91.10.4155","article-title":"Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons","volume":"91","author":"Rothstein","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib481","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1139\/o83-118","article-title":"Pharmacological antagonism of calmodulin","volume":"61","author":"Roufogalis","year":"1983","journal-title":"Can J Biochem Cell Biol"},{"key":"10.1124\/pr.107.00107_bib482","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0028-3908(98)00094-X","article-title":"Elevation of extracellular cortical noradrenaline may contribute to the antidepressant activity of zotepine: an in vivo microdialysis study in freely moving rats","volume":"37","author":"Rowley","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.107.00107_bib483","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s002109900170","article-title":"A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo","volume":"361","author":"Rowley","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pr.107.00107_bib484","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2005.08.029","article-title":"A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities","volume":"59","author":"Rujescu","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib485","first-page":"240","article-title":"The methodical use of hypoglycemia in the treatment of psychoses","volume":"151","author":"Sakel","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib486","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.57.5.471","article-title":"Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms","volume":"57","author":"Sanfilipo","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib487","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib488","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/schbul\/sbi006","article-title":"Cortical cholinergic transmission and cortical information processing in schizophrenia","volume":"31","author":"Sarter","year":"2005","journal-title":"Schizophr Bull"},{"key":"10.1124\/pr.107.00107_bib489","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2000.0740001.x","article-title":"Apoptosis and the nervous system","volume":"74","author":"Sastry","year":"2000","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib490","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/MCB.19.4.2435","article-title":"Mitogen-activated protein kinases: specific messages from ubiquitous messengers","volume":"19","author":"Schaeffer","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1124\/pr.107.00107_bib491","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0893-133X(00)00172-X","article-title":"The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics","volume":"24","author":"Scheepers","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib492","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1176\/appi.ajp.158.4.644","article-title":"Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia","volume":"158","author":"Scheepers","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib493","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1073\/pnas.94.21.11357","article-title":"Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2","volume":"94","author":"Schlesinger","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib494","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0022-3565(25)13106-6","article-title":"Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade","volume":"277","author":"Schmidt","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib495","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(03)00653-0","article-title":"Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain","volume":"347","author":"Schmitt","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib496","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00406-005-0618-2","article-title":"Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-na\u00efve schizophrenia patients","volume":"256","author":"Schmitt","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1124\/pr.107.00107_bib497","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00001756-199801050-00026","article-title":"Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum","volume":"9","author":"Schneider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1124\/pr.107.00107_bib498","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.107.00107_bib499","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1007152904926","article-title":"Steroid synthesis and metabolism in the nervous system: trophic and protective effects","volume":"29","author":"Schumacher","year":"2000","journal-title":"J Neurocytol"},{"key":"10.1124\/pr.107.00107_bib500","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib501","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0024-3205(89)90600-0","article-title":"Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors","volume":"44","author":"See","year":"1989","journal-title":"Life Sci"},{"key":"10.1124\/pr.107.00107_bib502","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)12023-5","article-title":"Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity","volume":"275","author":"Seeger","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib503","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/syn.20368","article-title":"Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and postmortem schizophrenia brain","volume":"61","author":"Seeman","year":"2007","journal-title":"Synapse"},{"key":"10.1124\/pr.107.00107_bib504","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1124\/pr.107.00107_bib505","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/syn.20303","article-title":"Psychosis pathways converge via D2High dopamine receptors","volume":"60","author":"Seeman","year":"2006","journal-title":"Synapse"},{"key":"10.1124\/pr.107.00107_bib506","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.156.6.876","article-title":"Rapid release of antipsychotic drugs from dopamine D2 receptors: An explanation for low receptor occupancy and early clinical relapse upon drug withdrawal of clozapine or quetiapine","volume":"156","author":"Seeman","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib507","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0006-3223(98)00281-9","article-title":"The reduced neuropil hypothesis: a circuit based model of schizophrenia","volume":"45","author":"Selemon","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib508","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1300.066","article-title":"Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions","volume":"1003","author":"Sesack","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/pr.107.00107_bib509","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib510","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00406-007-0757-8","article-title":"Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site","volume":"258","author":"Shim","year":"2008","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1124\/pr.107.00107_bib511","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2003.08.004","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls","volume":"351","author":"Shimizu","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib512","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib513","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.euroneuro.2004.12.005","article-title":"The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia","volume":"15","author":"Shoval","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib514","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/070674370505001109","article-title":"Neuroactive steroids in schizophrenia","volume":"50","author":"Shulman","year":"2005","journal-title":"Can J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib515","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1176\/appi.ajp.158.2.234","article-title":"Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms","volume":"158","author":"Sigmundsson","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib516","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/sj.jcbfm.9600521","article-title":"Supply and demand in cerebral energy metabolism: the role of nutrient transporters","volume":"27","author":"Simpson","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/pr.107.00107_bib517","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/exnr.1993.1071","article-title":"Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum","volume":"121","author":"Simpson","year":"1993","journal-title":"Exp Neurol"},{"key":"10.1124\/pr.107.00107_bib518","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004010000297","article-title":"Erythropoietin and erythropoietin receptor in human ischemic\/hypoxic brain","volume":"101","author":"Sir\u00e9n","year":"2001","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1124\/pr.107.00107_bib519","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0014-2999(95)00260-R","article-title":"Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat","volume":"281","author":"Skarsfeldt","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib520","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.pnpbp.2007.10.003","article-title":"Antipsychotic drug administration differentially affects [3H]muscimol and [3H]flunitrazepam GABAA receptor binding sites","volume":"32","author":"Skilbeck","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib521","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","article-title":"Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus","volume":"15","author":"Smith","year":"1995","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib522","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(99)00048-5","article-title":"Redox mechanisms at the glutamate synapse and their significance: a review","volume":"370","author":"Smythies","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib523","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair","volume":"24","author":"Sofroniew","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/pr.107.00107_bib524","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01474687","article-title":"Reduced [3H] flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?","volume":"18","author":"Squires","year":"1993","journal-title":"Neurochem Res"},{"key":"10.1124\/pr.107.00107_bib525","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.188.6.510","article-title":"Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies","volume":"188","author":"Steen","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib526","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuroscience.2005.10.014","article-title":"Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia","volume":"137","author":"Steullet","year":"2006","journal-title":"Neuroscience"},{"key":"10.1124\/pr.107.00107_bib527","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0893-133X(94)00130-R","article-title":"Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons","volume":"14","author":"Stockton","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib528","article-title":"Cortical dopamine D2\/D3 receptors are a common site of action for antipsychotic drugs\u2014an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature","author":"Stone","year":"2008","journal-title":"Schizophr Bull"},{"key":"10.1124\/pr.107.00107_bib529","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/bmj.2.4775.64","article-title":"Use of dehydroisoandrosterone in psychiatric treatment; a preliminary survey","volume":"2","author":"Strauss","year":"1952","journal-title":"Br Med J"},{"key":"10.1124\/pr.107.00107_bib530","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archpsyc.60.2.133","article-title":"Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia","volume":"60","author":"Strous","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib531","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145703003900","article-title":"Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms","volume":"7","author":"Sumiyoshi","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib532","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI200317977","article-title":"VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia","volume":"111","author":"Sun","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.107.00107_bib533","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.1089681","article-title":"Diverse psychotomimetics act through a common signaling pathway","volume":"302","author":"Svenningsson","year":"2003","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib534","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-3223(92)90046-3","article-title":"Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study","volume":"31","author":"Swayze","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib535","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.conb.2004.04.001","article-title":"Mitogen-activated protein kinases in synaptic plasticity and memory","volume":"14","author":"Sweatt","year":"2004","journal-title":"Curr Opin Neurobiol"},{"key":"10.1124\/pr.107.00107_bib536","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0022-3565(25)21289-7","article-title":"Seroquel restores sensorimotor gating in phencyclidine-treated rats","volume":"279","author":"Swerdlow","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib537","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.20","article-title":"Schizophrenia and glutamatergic transmission","volume":"12","author":"Tamminga","year":"1998","journal-title":"Crit Rev Neurobiol"},{"key":"10.1124\/pr.107.00107_bib538","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2005.02.054","article-title":"Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics","volume":"382","author":"Tan","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib539","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0022-3565(24)36573-5","article-title":"PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties","volume":"281","author":"Tang","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib540","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.schres.2004.07.023","article-title":"Superior temporal gyrus differences in childhood-onset schizophrenia","volume":"73","author":"Taylor","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib541","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.105.099218","article-title":"Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons and spatial learning in rats","volume":"318","author":"Terry","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib542","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers","volume":"159","author":"Th\u00e9berge","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib543","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.270.5236.593","article-title":"Neurotrophins and neuronal plasticity","volume":"270","author":"Thoenen","year":"1995","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib544","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.psc.2004.06.004","article-title":"The basal ganglia: anatomy, physiology, and pharmacology","volume":"27","author":"Tisch","year":"2004","journal-title":"Psychiatr Clin North Am"},{"key":"10.1124\/pr.107.00107_bib545","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0140-6736(03)14289-4","article-title":"Oligodendrocyte dysfunction in schizophrenia and bipolar disorder","volume":"362","author":"Tkachev","year":"2003","journal-title":"Lancet"},{"key":"10.1124\/pr.107.00107_bib546","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/0024-3205(96)00494-8","article-title":"Diazepam physical dependence and withdrawal in rats is associated with alteration in GABAA receptor function","volume":"59","author":"Toki","year":"1996","journal-title":"Life Sci"},{"key":"10.1124\/pr.107.00107_bib547","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000054937","article-title":"Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine","volume":"44","author":"Tortorella","year":"2001","journal-title":"Neuropsychobiology"},{"key":"10.1124\/pr.107.00107_bib548","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0447.1988.tb06312.x","article-title":"Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients","volume":"78","author":"Toru","year":"1988","journal-title":"Acta Psychiatr Scand"},{"key":"10.1124\/pr.107.00107_bib549","first-page":"909.1","article-title":"Schizophrenia patients show reduced expression of the glutathione related genes","volume":"30","author":"Tosic","year":"2004","journal-title":"Soc Neurosci Abstr"},{"key":"10.1124\/pr.107.00107_bib550","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-1781(02)00127-0","article-title":"Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients","volume":"110","author":"Toyooka","year":"2002","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib551","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archpsyc.1995.03950220039008","article-title":"Abnormal excitatory neurotransmitter metabolism in schizophrenia brains","volume":"52","author":"Tsai","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib552","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2003.11.059","article-title":"Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice","volume":"357","author":"Turalba","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib553","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/sj.npp.1300460","article-title":"Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents","volume":"29","author":"Ugale","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib554","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00702-004-0109-z","article-title":"Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol","volume":"111","author":"Ukai","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1124\/pr.107.00107_bib555","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine","volume":"95","author":"Uzunova","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib556","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1460-9568.2004.03278.x","article-title":"Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain","volume":"19","author":"Valjent","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.107.00107_bib557","doi-asserted-by":"crossref","first-page":"14865","DOI":"10.1073\/pnas.94.26.14865","article-title":"Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus","volume":"94","author":"Vall\u00e9e","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib558","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0960-0760(03)00227-9","article-title":"Neuroactive steroids: new biomarkers of cognitive aging","volume":"85","author":"Vall\u00e9e","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/pr.107.00107_bib559","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/glia.20172","article-title":"Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures","volume":"50","author":"Vallejo-Illarramendi","year":"2005","journal-title":"Glia"},{"key":"10.1124\/pr.107.00107_bib560","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.euroneuro.2003.09.002","article-title":"Atypical antipsychotics and the relevance of glutamate and serotonin","volume":"14","author":"van der Heijden","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.107.00107_bib561","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.npp.1301347","article-title":"Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study","volume":"32","author":"van Haren","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib562","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1073\/pnas.2637013100","article-title":"DNA methyltransferase-1 (DNMT1) is selectively overexpressed in telencephalic cortical GABAergic interneurons of schizophrenia brains","volume":"101","author":"Veldic","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib563","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1073\/pnas.0409665102","article-title":"In psychosis, cortical interneurons overexpress DNA-methyltransferase 1","volume":"102","author":"Veldic","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pr.107.00107_bib564","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1460-9568.2007.05769.x","article-title":"d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia","volume":"26","author":"Verrall","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.107.00107_bib565","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1471-4159.1997.69010182.x","article-title":"BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex","volume":"69","author":"Volont\u00e9","year":"1997","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib566","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jnr.10281","article-title":"Atypical neuroleptics stimulate neurogenesis in adult rat brain","volume":"69","author":"Wakade","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib567","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.neubiorev.2006.02.001","article-title":"Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia","volume":"30","author":"Walterfang","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pr.107.00107_bib568","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuroscience.2004.02.003","article-title":"Blockade of N-methyl-d-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons","volume":"125","author":"Wang","year":"2004","journal-title":"Neuroscience"},{"key":"10.1124\/pr.107.00107_bib569","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bcp.2005.02.013","article-title":"The role of NMDA receptor upregulation in phencyclidine-induced cortical apoptosis in organotypic culture","volume":"69","author":"Wang","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.107.00107_bib570","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-3565(24)39068-8","article-title":"Mechanisms of N-methyl-d-aspartate-induced apoptosis in phencyclidine-treated cultured forebrain neurons","volume":"294","author":"Wang","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib571","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0306-4522(01)00384-0","article-title":"Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia","volume":"107","author":"Wang","year":"2001","journal-title":"Neuroscience"},{"key":"10.1124\/pr.107.00107_bib572","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.102.041798","article-title":"Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic","volume":"304","author":"Wang","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib573","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jnr.20559","article-title":"Differential effects of acute and subchronic administration on phencyclidine-induced neurodegeneration in the perinatal rat","volume":"81","author":"Wang","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib574","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/sj.npp.1301202","article-title":"The role of caspase-3 activation in phencyclidine-induced neuronal death in postnatal rats","volume":"32","author":"Wang","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib575","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/sj.npp.1301647","article-title":"Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons","volume":"33","author":"Wang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib576","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.npp.1301521","article-title":"Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment","volume":"33","author":"Wang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib577","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/sj.npp.1300449","article-title":"Effect of antipsychotic drugs on neurogenesis in the forebrain of the adult rat","volume":"29","author":"Wang","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib578","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jnr.20570","article-title":"Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25\u201335)-induced oxidative stress and the ensuing apoptosis","volume":"81","author":"Wang","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib579","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1523\/JNEUROSCI.4520-04.2005","article-title":"The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression","volume":"25","author":"Wang","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.107.00107_bib580","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0893-133X(98)00003-7","article-title":"M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice","volume":"19","author":"Wang","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib581","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.jcp.0000095349.32154.a5","article-title":"GABA and schizophrenia: a review of basic science and clinical studies","volume":"23","author":"Wassef","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/pr.107.00107_bib582","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jnr.10668","article-title":"Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide","volume":"73","author":"Wei","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib583","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/jnr.10832","article-title":"Atypical antipsychotics attenuate neurotoxicity of \u03b2-amyloid(25\u201335) by modulating Bax and Bcl-X(l\/s) expression and localization","volume":"74","author":"Wei","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.107.00107_bib584","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.mp.4001308","article-title":"Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia","volume":"8","author":"Weickert","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib585","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.mp.4001678","article-title":"Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia","volume":"10","author":"Weickert","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib586","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archpsyc.1988.01800310013001","article-title":"Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism","volume":"45","author":"Weinberger","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib587","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archpsyc.1986.01800020020004","article-title":"Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence","volume":"43","author":"Weinberger","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/pr.107.00107_bib588","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-3565(24)29327-7","article-title":"5-Hydroxytryptamine2A receptor inverse agonists as antipsychotics","volume":"299","author":"Weiner","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.107.00107_bib589","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00004714-199908000-00017","article-title":"Biochemical and possible neuropsychopharmacological implications of inhibiting calmodulin activity","volume":"19","author":"Weiss","year":"1983","journal-title":"Psychopharmacol Bull"},{"key":"10.1124\/pr.107.00107_bib590","first-page":"223","article-title":"3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons","volume":"248","author":"Weller","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib591","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1126\/science.6136093","article-title":"Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons","volume":"221","author":"White","year":"1983","journal-title":"Science"},{"key":"10.1124\/pr.107.00107_bib592","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1359-6446(03)02703-X","article-title":"GABAA receptor subtypes n the brain: a paradigm for CNS drug discovery?","volume":"8","author":"Whiting","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1124\/pr.107.00107_bib593","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(91)91658-N","article-title":"Anxiolytic activity of the progesterone metabolite 5\u03b1-pregnan-3\u03b1-o1\u201320-one","volume":"565","author":"Wieland","year":"1991","journal-title":"Brain Res"},{"key":"10.1124\/pr.107.00107_bib594","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0091-3057(92)90433-G","article-title":"Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure","volume":"43","author":"Wiley","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.107.00107_bib595","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.142.5.564","article-title":"Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography","volume":"142","author":"Wolkin","year":"1985","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib596","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.neuron.2007.04.009","article-title":"Neuregulin-1 enhances depolarization-induced GABA release","volume":"54","author":"Woo","year":"2007","journal-title":"Neuron"},{"key":"10.1124\/pr.107.00107_bib597","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1534582302001001002","article-title":"Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer\u2019s disease and schizophrenia","volume":"1","author":"Woodruff-Pak","year":"2002","journal-title":"Behav Cogn Neurosci Rev"},{"key":"10.1124\/pr.107.00107_bib598","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1176\/ajp.155.12.1661","article-title":"Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism","volume":"155","author":"Woods","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib599","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1176\/ajp.157.1.16","article-title":"Meta-analysis of regional brain volumes in schizophrenia","volume":"157","author":"Wright","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.107.00107_bib600","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1471-4159.1997.69010174.x","article-title":"N-Aceylaspartylglutamate selectively activates mGluR3 receptors in transfected cells","volume":"69","author":"Wroblewska","year":"1997","journal-title":"J Neurochem"},{"key":"10.1124\/pr.107.00107_bib601","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0026-895X(25)12923-4","article-title":"Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor","volume":"40","author":"Wu","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.107.00107_bib602","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02736752","article-title":"Subunit- and brain region-specific reduction of GABAA receptor subunit mRNAs during chronic treatment of rats with diazepam","volume":"5","author":"Wu","year":"1994","journal-title":"J Mol Neurosci"},{"key":"10.1124\/pr.107.00107_bib603","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/schbul\/17.2.325","article-title":"Neuroleptics and the natural course of schizophrenia","volume":"17","author":"Wyatt","year":"1991","journal-title":"Schizophr Bull"},{"key":"10.1124\/pr.107.00107_bib604","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(02)00034-4","article-title":"Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus","volume":"321","author":"Xu","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib605","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.biopsych.2005.03.018","article-title":"Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels","volume":"57","author":"Yamada","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib606","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0301-0082(99)00007-6","article-title":"Subunit- and site-specific pharmacology of the NMDA receptor channel","volume":"59","author":"Yamakura","year":"1999","journal-title":"Prog Neurobiol"},{"issue":"Suppl B","key":"10.1124\/pr.107.00107_bib607","first-page":"8","article-title":"Brain region effects of clozapine on amino acid and monoamine transmission","volume":"55","author":"Yamamoto","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pr.107.00107_bib608","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pnpbp.2004.05.033","article-title":"Proposal for a noradrenaline hypothesis of schizophrenia","volume":"28","author":"Yamamoto","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.107.00107_bib609","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cne.1121","article-title":"Expression of active caspase-3 in mitotic and postmitotic cells of the rat forebrain","volume":"433","author":"Yan","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.107.00107_bib610","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1440-1819.2004.01229.x","article-title":"Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration","volume":"58","author":"Yang","year":"2004","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1124\/pr.107.00107_bib611","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/syn.20123","article-title":"Effects of haloperidol and clozapine on glutamate release from nerve terminals isolated from rat prefrontal cortex","volume":"56","author":"Yang","year":"2005","journal-title":"Synapse"},{"key":"10.1124\/pr.107.00107_bib612","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.schbul.a007142","article-title":"Increased nitric oxide radicals in postmortem brain from patients with schizophrenia","volume":"30","author":"Yao","year":"2004","journal-title":"Schizophr Bull"},{"key":"10.1124\/pr.107.00107_bib613","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Dis Markers"},{"key":"10.1124\/pr.107.00107_bib614","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.WNL.0000150591.33787.A4","article-title":"Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease","volume":"64","author":"Zaja-Milatovic","year":"2005","journal-title":"Neurology"},{"key":"10.1124\/pr.107.00107_bib615","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0893-133X(00)00119-6","article-title":"Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex","volume":"23","author":"Zhang","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.107.00107_bib616","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","article-title":"Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics","volume":"81","author":"Zhang","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib617","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-1781(02)00303-7","article-title":"Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms","volume":"117","author":"Zhang","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1124\/pr.107.00107_bib618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2006.02.009","article-title":"Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction","volume":"84","author":"Zhao","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib619","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2004-827173","article-title":"Differential effects of long-term treatment with clozapine or haloperidol on GABA transporter expression","volume":"37","author":"Zink","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/pr.107.00107_bib620","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-9964(03)00088-4","article-title":"Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression","volume":"66","author":"Zink","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1124\/pr.107.00107_bib621","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2005.06.035","article-title":"Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex","volume":"387","author":"Zocchi","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.107.00107_bib622","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0922-4106(94)90047-7","article-title":"Clozapine is a potent and selective muscarinic M4 receptor agonist","volume":"269","author":"Zorn","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.107.00107_bib623","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.lfs.2005.09.022","article-title":"Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior","volume":"78","author":"Zuo","year":"2006","journal-title":"Life Sci"}],"updated-by":[{"DOI":"10.1016\/s0031-6997(24)00817-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000}}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003169972400807X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003169972400807X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.107.00107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:44:12Z","timestamp":1739871852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003169972400807X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":623,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S003169972400807X"],"URL":"https:\/\/doi.org\/10.1124\/pr.107.00107","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/S0031-6997(24)00817-2","asserted-by":"object"}]},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.107.00107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}